Jacob van Naarden is COO at Loxo Oncology, Inc. (LOXO). They have made 36 open-market trades across 2 companies since 2017, most recently 2026-02-09.
CIK 0001661254
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $647K since 2025, against 35 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| LLY | BUY | 2025-08-13 | 2025-08-13 | $647.36 | $647K | +5.0% | +14.1% | +49.3% |
| LOXO | SELL | 2018-12-11 | 2018-12-12 | $137.32 | $426K | -7.2% | +66.7% | N/A |
| LOXO | SELL | 2018-12-10 | 2018-12-12 | $135.50 | $1.2M | -7.2% | +66.7% | N/A |
| LOXO | SELL | 2018-12-10 | 2018-12-12 | $133.17 | $120K | -7.2% | +66.7% | N/A |
| LOXO | SELL | 2018-11-27 | 2018-11-28 | $138.49 | $293K | -5.4% | -7.5% | N/A |
| LOXO | SELL | 2018-11-26 | 2018-11-28 | $147.97 | $1.5M | -5.4% | -7.5% | N/A |
| LOXO | SELL | 2018-11-26 | 2018-11-28 | $152.11 | $487K | -5.4% | -7.5% | N/A |
| LOXO | SELL | 2018-10-04 | 2018-10-05 | $162.64 | $732K | +5.9% | +9.5% | -17.5% |
| LOXO | SELL | 2018-10-03 | 2018-10-05 | $164.78 | $2.0M | +5.9% | +9.5% | -17.5% |
| LOXO | SELL | 2018-10-03 | 2018-10-05 | $167.03 | $869K | +5.9% | +9.5% | -17.5% |
| LOXO | SELL | 2018-09-13 | 2018-09-14 | $165.98 | $747K | +6.0% | -2.1% | -13.6% |
| LOXO | SELL | 2018-09-12 | 2018-09-14 | $166.52 | $883K | +6.0% | -2.1% | -13.6% |
| LOXO | SELL | 2018-09-12 | 2018-09-14 | $166.13 | $2.4M | +6.0% | -2.1% | -13.6% |
| LOXO | SELL | 2018-08-14 | 2018-08-15 | $159.92 | $720K | +4.0% | +3.4% | +0.3% |
| LOXO | SELL | 2018-08-13 | 2018-08-15 | $159.32 | $2.9M | +4.0% | +3.4% | +0.3% |
| LOXO | SELL | 2018-08-13 | 2018-08-15 | $158.81 | $842K | +4.0% | +3.4% | +0.3% |
| LOXO | SELL | 2018-07-09 | 2018-07-11 | $182.99 | $872K | -5.0% | -13.4% | -8.6% |
| LOXO | SELL | 2018-06-19 | 2018-06-21 | $177.73 | $804K | -2.1% | -5.0% | -15.3% |
| LOXO | SELL | 2018-05-14 | 2018-05-16 | $137.78 | $636K | +4.9% | +10.2% | -0.5% |
| LOXO | SELL | 2018-04-24 | 2018-04-26 | $131.36 | $476K | -6.8% | +26.4% | +27.3% |
| LOXO | SELL | 2018-03-13 | 2018-03-15 | $131.51 | $666K | -7.4% | +8.5% | +47.1% |
| LOXO | SELL | 2018-02-12 | 2018-02-14 | $96.97 | $472K | +5.7% | +18.0% | +31.8% |
| LOXO | SELL | 2018-01-17 | 2018-01-18 | $89.23 | $62K | +14.0% | +15.3% | +48.2% |
| LOXO | SELL | 2018-01-16 | 2018-01-18 | $88.00 | $463K | +14.0% | +15.3% | +48.2% |
| LOXO | SELL | 2018-01-16 | 2018-01-18 | $86.53 | $55K | +14.0% | +15.3% | +48.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.